Nov 2015;76:106-17
However, the present review highlights critical demerits of these lines of evidence: the FAERS data were voluntary and clinically unverified, and the Bezin et al
Legal and regulatory risks Not approved as a drug, supplement, or food in the US, EU, Australia, and other major markets
Proteins in the samples were precipitated by boiling or treating with 10 % cold perchloric acid and then centrifuging at 4 C and 12,000 rpm for 10 min
A year later, a team led by Graeme Bell at Chiron Corporation in California cloned and sequenced the versions found in humans and other mammals, which they dubbed GLP-1 and GLP-2, for glucagon-like peptides
10.1124/pr.120.019240 Pharmacol Rev